Monopar Therapeutics, Inc. (MNPR)
53.47
-1.34
(-2.44%)
USD |
NASDAQ |
Mar 02, 16:00
53.50
+0.03
(+0.06%)
After-Hours: 20:00
Monopar Therapeutics Market Cap : 357.32M for March 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Plus Therapeutics, Inc. | 41.17M |
| BioStem Technologies, Inc. | 93.05M |
| Iovance Biotherapeutics, Inc. | 1.505B |
| Protokinetix, Inc. | 2.624M |
| GB Sciences, Inc. | 0.1221M |
Market Cap Related Metrics
| PEG Ratio | -0.2116 |
| Price to Book Value | 2.524 |
| Price | 53.47 |
| Earnings Yield | -6.43% |
| PEGY Ratio | -0.2116 |